|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/06 | (2006.01) |
| (11) | Number of the document | 3515490 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17853838.5 |
| Date of filing the European patent application | 2017-09-20 | |
| (97) | Date of publication of the European application | 2019-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-10 |
| (46) | Date of publication of the claims translation | 2022-11-10 |
| (86) | Number | PCT/US2017/052592 |
| Date | 2017-09-20 |
| (87) | Number | WO 2018/057669 |
| Date | 2018-03-29 |
| (30) | Number | Date | Country code |
| 201662397752 P | 2016-09-21 | US | |
| 201762515480 P | 2017-06-05 | US |
| (72) |
PONS, Jaume , US
SIM, Bang Janet , US
WAN, Hong , US
KUO, Tracy Chia-Chien , US
KAUDER, Steven Elliot , US
HARRIMAN, William Don , US
IZQUIERDO, Shelley , US
|
| (73) |
ALX Oncology Inc. ,
323 Allerton Avenue South, San Francisco, CA 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai prieš signalą reguliuojantį baltymą alfa, ir naudojimo būdai |
| ANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USE |
| Payment date | Validity (years) | Amount | |
| 2025-08-27 | 9 | 208.00 EUR |
| 2026-09-20 |